These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6136102)

  • 81. Medical therapy of extraesophageal gastroesophageal reflux disease.
    Katz PO
    J Clin Gastroenterol; 2000 Apr; 30(3 Suppl):S42-4. PubMed ID: 10777172
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Gastro-oesophageal reflux disease.
    Moayyedi P; Delaney B; Forman D
    Clin Evid; 2004 Jun; (11):583-600. PubMed ID: 15652024
    [No Abstract]   [Full Text] [Related]  

  • 84. Gastro-oesophageal reflux disease.
    Moayyedi P; Delaney B; Forman D
    Clin Evid; 2005 Dec; (14):567-81. PubMed ID: 16620423
    [No Abstract]   [Full Text] [Related]  

  • 85. Control of gastric acid secretion in health and disease.
    Schubert ML; Peura DA
    Gastroenterology; 2008 Jun; 134(7):1842-60. PubMed ID: 18474247
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Ebrotidine: an new alternative in peptic acid diseases].
    Piqué JM
    Med Clin (Barc); 1997 Mar; 108(8):301-3. PubMed ID: 9121207
    [No Abstract]   [Full Text] [Related]  

  • 87. [Clinical treating of antacids].
    Lux G; Lux E
    Fortschr Med; 1973 May; 91(14):638-40. PubMed ID: 4540765
    [No Abstract]   [Full Text] [Related]  

  • 88. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Singh G; Fries JF
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992334
    [No Abstract]   [Full Text] [Related]  

  • 90. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Treatment of gastroesophageal reflux disease: to step or not to step.
    McGuigan JE
    Am J Gastroenterol; 2001 Jun; 96(6):1679-81. PubMed ID: 11419813
    [No Abstract]   [Full Text] [Related]  

  • 92. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Gastro-oesophageal reflux disease.
    Moayyedi P; Delaney B; Forman D
    Clin Evid; 2003 Jun; (9):496-512. PubMed ID: 12967375
    [No Abstract]   [Full Text] [Related]  

  • 94. Over the counter sales of histamine-2 receptor antagonists.
    Petersen H
    Scand J Gastroenterol Suppl; 1988; 155():20-2. PubMed ID: 2907682
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Contemporary issues in gastrointestinal diseases for clinical pharmacists. Proceedings of a symposium. April 22-24, 1988, Panama Beach, Florida.
    DICP; 1989 Oct; 23(10 Suppl):S1-46. PubMed ID: 2573204
    [No Abstract]   [Full Text] [Related]  

  • 96. Evolving perspectives on parenteral H2-receptor antagonist therapy. Symposium. Tucson, Arizona, April l0-11, 1987.
    Am J Med; 1987 Dec; 83(6A):1-88. PubMed ID: 2892404
    [No Abstract]   [Full Text] [Related]  

  • 97. Famotidine: a further development in the modern treatment of peptic ulcer disease. Proceedings of a satellite symposium of the XIIth International Congress of Gastroenterology. Lisbon, September 19, 1984.
    Digestion; 1985; 32 Suppl 1():1-72. PubMed ID: 2866131
    [No Abstract]   [Full Text] [Related]  

  • 98. Gastric cytoprotection. What does it really mean for the prescriber?
    Guslandi M
    Drugs; 1991 Apr; 41(4):507-13. PubMed ID: 1711956
    [No Abstract]   [Full Text] [Related]  

  • 99. Histamine-2-receptor antagonists in gastro-oesophageal reflux.
    Colin-Jones DG
    Gut; 1989 Oct; 30(10):1305-8. PubMed ID: 2573565
    [No Abstract]   [Full Text] [Related]  

  • 100. Comment: peptic ulcer H2-receptor antagonist therapy.
    Kinniry A; Antell L; Murabito AS
    Drug Intell Clin Pharm; 1988 Sep; 22(9):728-30. PubMed ID: 2905639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.